IBDEI34X ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,50067,1,3,0)
;;=3^Psoriasis,Unspec
;;^UTILITY(U,$J,358.3,50067,1,4,0)
;;=4^L40.9
;;^UTILITY(U,$J,358.3,50067,2)
;;=^5009171
;;^UTILITY(U,$J,358.3,50068,0)
;;=L50.9^^193^2487^326
;;^UTILITY(U,$J,358.3,50068,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50068,1,3,0)
;;=3^Urticaria,Unspec
;;^UTILITY(U,$J,358.3,50068,1,4,0)
;;=4^L50.9
;;^UTILITY(U,$J,358.3,50068,2)
;;=^5009204
;;^UTILITY(U,$J,358.3,50069,0)
;;=L53.8^^193^2487^150
;;^UTILITY(U,$J,358.3,50069,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50069,1,3,0)
;;=3^Erythematous Conditions NEC
;;^UTILITY(U,$J,358.3,50069,1,4,0)
;;=4^L53.8
;;^UTILITY(U,$J,358.3,50069,2)
;;=^88044
;;^UTILITY(U,$J,358.3,50070,0)
;;=L53.9^^193^2487^149
;;^UTILITY(U,$J,358.3,50070,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50070,1,3,0)
;;=3^Erythematous Condition,Unspec
;;^UTILITY(U,$J,358.3,50070,1,4,0)
;;=4^L53.9
;;^UTILITY(U,$J,358.3,50070,2)
;;=^5009210
;;^UTILITY(U,$J,358.3,50071,0)
;;=L54.^^193^2487^148
;;^UTILITY(U,$J,358.3,50071,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50071,1,3,0)
;;=3^Erythema in Diseases Classified Elsewhere
;;^UTILITY(U,$J,358.3,50071,1,4,0)
;;=4^L54.
;;^UTILITY(U,$J,358.3,50071,2)
;;=^5009211
;;^UTILITY(U,$J,358.3,50072,0)
;;=L56.0^^193^2487^142
;;^UTILITY(U,$J,358.3,50072,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50072,1,3,0)
;;=3^Drug Phototoxic Response
;;^UTILITY(U,$J,358.3,50072,1,4,0)
;;=4^L56.0
;;^UTILITY(U,$J,358.3,50072,2)
;;=^5009214
;;^UTILITY(U,$J,358.3,50073,0)
;;=L56.1^^193^2487^141
;;^UTILITY(U,$J,358.3,50073,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50073,1,3,0)
;;=3^Drug Photoallergic Response
;;^UTILITY(U,$J,358.3,50073,1,4,0)
;;=4^L56.1
;;^UTILITY(U,$J,358.3,50073,2)
;;=^5009215
;;^UTILITY(U,$J,358.3,50074,0)
;;=L56.2^^193^2487^274
;;^UTILITY(U,$J,358.3,50074,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50074,1,3,0)
;;=3^Photocontact Dermatitis
;;^UTILITY(U,$J,358.3,50074,1,4,0)
;;=4^L56.2
;;^UTILITY(U,$J,358.3,50074,2)
;;=^5009216
;;^UTILITY(U,$J,358.3,50075,0)
;;=L56.3^^193^2487^308
;;^UTILITY(U,$J,358.3,50075,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50075,1,3,0)
;;=3^Solar Urticaria
;;^UTILITY(U,$J,358.3,50075,1,4,0)
;;=4^L56.3
;;^UTILITY(U,$J,358.3,50075,2)
;;=^5009217
;;^UTILITY(U,$J,358.3,50076,0)
;;=L57.0^^193^2487^13
;;^UTILITY(U,$J,358.3,50076,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50076,1,3,0)
;;=3^Actinic Keratosis
;;^UTILITY(U,$J,358.3,50076,1,4,0)
;;=4^L57.0
;;^UTILITY(U,$J,358.3,50076,2)
;;=^66900
;;^UTILITY(U,$J,358.3,50077,0)
;;=L60.0^^193^2487^164
;;^UTILITY(U,$J,358.3,50077,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50077,1,3,0)
;;=3^Ingrowing Nail
;;^UTILITY(U,$J,358.3,50077,1,4,0)
;;=4^L60.0
;;^UTILITY(U,$J,358.3,50077,2)
;;=^5009234
;;^UTILITY(U,$J,358.3,50078,0)
;;=L60.1^^193^2487^272
;;^UTILITY(U,$J,358.3,50078,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50078,1,3,0)
;;=3^Onycholysis
;;^UTILITY(U,$J,358.3,50078,1,4,0)
;;=4^L60.1
;;^UTILITY(U,$J,358.3,50078,2)
;;=^186837
;;^UTILITY(U,$J,358.3,50079,0)
;;=L60.2^^193^2487^271
;;^UTILITY(U,$J,358.3,50079,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50079,1,3,0)
;;=3^Onychogryphosis
;;^UTILITY(U,$J,358.3,50079,1,4,0)
;;=4^L60.2
;;^UTILITY(U,$J,358.3,50079,2)
;;=^5009235
;;^UTILITY(U,$J,358.3,50080,0)
;;=L60.3^^193^2487^176
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI34X 3771 printed Apr 09, 2024@21:02 Page 2
IBDEI34X ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,50067,1,3,0)
+2 ;;=3^Psoriasis,Unspec
+3 ;;^UTILITY(U,$J,358.3,50067,1,4,0)
+4 ;;=4^L40.9
+5 ;;^UTILITY(U,$J,358.3,50067,2)
+6 ;;=^5009171
+7 ;;^UTILITY(U,$J,358.3,50068,0)
+8 ;;=L50.9^^193^2487^326
+9 ;;^UTILITY(U,$J,358.3,50068,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,50068,1,3,0)
+12 ;;=3^Urticaria,Unspec
+13 ;;^UTILITY(U,$J,358.3,50068,1,4,0)
+14 ;;=4^L50.9
+15 ;;^UTILITY(U,$J,358.3,50068,2)
+16 ;;=^5009204
+17 ;;^UTILITY(U,$J,358.3,50069,0)
+18 ;;=L53.8^^193^2487^150
+19 ;;^UTILITY(U,$J,358.3,50069,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,50069,1,3,0)
+22 ;;=3^Erythematous Conditions NEC
+23 ;;^UTILITY(U,$J,358.3,50069,1,4,0)
+24 ;;=4^L53.8
+25 ;;^UTILITY(U,$J,358.3,50069,2)
+26 ;;=^88044
+27 ;;^UTILITY(U,$J,358.3,50070,0)
+28 ;;=L53.9^^193^2487^149
+29 ;;^UTILITY(U,$J,358.3,50070,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,50070,1,3,0)
+32 ;;=3^Erythematous Condition,Unspec
+33 ;;^UTILITY(U,$J,358.3,50070,1,4,0)
+34 ;;=4^L53.9
+35 ;;^UTILITY(U,$J,358.3,50070,2)
+36 ;;=^5009210
+37 ;;^UTILITY(U,$J,358.3,50071,0)
+38 ;;=L54.^^193^2487^148
+39 ;;^UTILITY(U,$J,358.3,50071,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,50071,1,3,0)
+42 ;;=3^Erythema in Diseases Classified Elsewhere
+43 ;;^UTILITY(U,$J,358.3,50071,1,4,0)
+44 ;;=4^L54.
+45 ;;^UTILITY(U,$J,358.3,50071,2)
+46 ;;=^5009211
+47 ;;^UTILITY(U,$J,358.3,50072,0)
+48 ;;=L56.0^^193^2487^142
+49 ;;^UTILITY(U,$J,358.3,50072,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,50072,1,3,0)
+52 ;;=3^Drug Phototoxic Response
+53 ;;^UTILITY(U,$J,358.3,50072,1,4,0)
+54 ;;=4^L56.0
+55 ;;^UTILITY(U,$J,358.3,50072,2)
+56 ;;=^5009214
+57 ;;^UTILITY(U,$J,358.3,50073,0)
+58 ;;=L56.1^^193^2487^141
+59 ;;^UTILITY(U,$J,358.3,50073,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,50073,1,3,0)
+62 ;;=3^Drug Photoallergic Response
+63 ;;^UTILITY(U,$J,358.3,50073,1,4,0)
+64 ;;=4^L56.1
+65 ;;^UTILITY(U,$J,358.3,50073,2)
+66 ;;=^5009215
+67 ;;^UTILITY(U,$J,358.3,50074,0)
+68 ;;=L56.2^^193^2487^274
+69 ;;^UTILITY(U,$J,358.3,50074,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,50074,1,3,0)
+72 ;;=3^Photocontact Dermatitis
+73 ;;^UTILITY(U,$J,358.3,50074,1,4,0)
+74 ;;=4^L56.2
+75 ;;^UTILITY(U,$J,358.3,50074,2)
+76 ;;=^5009216
+77 ;;^UTILITY(U,$J,358.3,50075,0)
+78 ;;=L56.3^^193^2487^308
+79 ;;^UTILITY(U,$J,358.3,50075,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,50075,1,3,0)
+82 ;;=3^Solar Urticaria
+83 ;;^UTILITY(U,$J,358.3,50075,1,4,0)
+84 ;;=4^L56.3
+85 ;;^UTILITY(U,$J,358.3,50075,2)
+86 ;;=^5009217
+87 ;;^UTILITY(U,$J,358.3,50076,0)
+88 ;;=L57.0^^193^2487^13
+89 ;;^UTILITY(U,$J,358.3,50076,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,50076,1,3,0)
+92 ;;=3^Actinic Keratosis
+93 ;;^UTILITY(U,$J,358.3,50076,1,4,0)
+94 ;;=4^L57.0
+95 ;;^UTILITY(U,$J,358.3,50076,2)
+96 ;;=^66900
+97 ;;^UTILITY(U,$J,358.3,50077,0)
+98 ;;=L60.0^^193^2487^164
+99 ;;^UTILITY(U,$J,358.3,50077,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,50077,1,3,0)
+102 ;;=3^Ingrowing Nail
+103 ;;^UTILITY(U,$J,358.3,50077,1,4,0)
+104 ;;=4^L60.0
+105 ;;^UTILITY(U,$J,358.3,50077,2)
+106 ;;=^5009234
+107 ;;^UTILITY(U,$J,358.3,50078,0)
+108 ;;=L60.1^^193^2487^272
+109 ;;^UTILITY(U,$J,358.3,50078,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,50078,1,3,0)
+112 ;;=3^Onycholysis
+113 ;;^UTILITY(U,$J,358.3,50078,1,4,0)
+114 ;;=4^L60.1
+115 ;;^UTILITY(U,$J,358.3,50078,2)
+116 ;;=^186837
+117 ;;^UTILITY(U,$J,358.3,50079,0)
+118 ;;=L60.2^^193^2487^271
+119 ;;^UTILITY(U,$J,358.3,50079,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,50079,1,3,0)
+122 ;;=3^Onychogryphosis
+123 ;;^UTILITY(U,$J,358.3,50079,1,4,0)
+124 ;;=4^L60.2
+125 ;;^UTILITY(U,$J,358.3,50079,2)
+126 ;;=^5009235
+127 ;;^UTILITY(U,$J,358.3,50080,0)
+128 ;;=L60.3^^193^2487^176
